About

Publications While At HealthPartners

selected publications

Journal Article

Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and II

2017

A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II

2016

Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI

2016

Elevated TNF-alpha is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VI. 

Molecular Genetics and Metabolism. 2016

Long-term cognitive and functional outcomes in children with mucopolysaccharidosis (MPS)-IH (Hurler syndrome) treated with hematopoietic cell transplantation

2016

Meal replacements followed by topiramate for the treatment of adolescent severe obesity: A pilot randomized controlled trial. 

Obesity (Silver Spring, Md.). 2016

Mucopolysaccharidosis (MPS) physical symptom score: development, reliability, and validity

2016

Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI. 

Journal of Pediatric Rehabilitation Medicine. 2014

Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot study. 

Obesity (Silver Spring, Md.). 2012

Abstract

TNF-a levels are increased in children with mucopolysaccharidosis types I, II, and VI treated with ERT [abstract]. 

Molecular Genetics and Metabolism. 2014

Contact

full name

K. D. Rudser

Quick Info

 

Collaboration

Co-author network

Map of science